文献速递肺结节与肺癌

低剂量CT影像引入与中国女性肺癌过度诊断

The Introduction of Low-Dose CT Imaging and Lung Cancer Overdiagnosis in Chinese Women.
PubMed 文献 · Chest · 2022-08-23

结果显示女性肺癌发病率自2011年起快速上升(年变化百分比11.98%,95%CI 9.57%-14.45%),而死亡率持续下降;男性早期肺癌发病率增加伴随晚期下降,女性早期发病率增加但晚期无显著下降,提示低剂量CT在低风险女性中可能导致肺癌过度诊断。

要点

  • 女性肺癌发病率2011年后快速上升,死亡率却持续下降,提示过度诊断可能。
  • 女性早期肺癌发病率增加16.1/10万,但晚期无显著下降。
  • 低剂量CT筛查在低风险人群中的应用需完善筛查标准与结节管理。

核心结论

  • 中国女性低风险人群中低剂量CT筛查增加的人群水平证据支持肺癌过度诊断的存在。

主要发现

  • 男性肺癌年龄调整发病率和死亡率至2008年显著下降后保持稳定;女性发病率自2011年快速上升(年变化百分比11.98%,95%CI 9.57%-14.45%),死亡率持续下降。
  • 两性肺癌发病率上升趋势主要见于肺腺癌,2012至2017年增长更陡。
  • 男性早期肺癌发病率增加6.9/10万(95%CI 5.1-8.7/10万),晚期下降5.5/10万(95%CI -9.2至-1.7/10万);女性早期发病率增加16.1/10万(95%CI 14.0-18.3/10万),晚期无显著下降(绝对差异-0.6/10万,95%CI -2.8至1.7/10万)。
  • 发病率比在最近时期最高,年轻女性增幅最大,主要为早期肺癌或肺腺癌。

临床怎么用

  • 呼吸科医生应关注低剂量CT筛查在低风险女性中可能导致的肺癌过度诊断风险。
  • 在临床实践中需综合评估筛查获益与过度诊断风险,并完善筛查检出结节的管理策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Overdiagnosis of lung cancer by low-dose CT (LDCT) screening has raised concerns globally. LDCT screening has been used widely in employee health examinations in China since 2011. RESEARCH QUESTION: Has the increasing use of LDCT in low-risk populations in China led to lung cancer overdiagnosis? STUDY DESIGN AND METHODS: A total of 34,152 incident cases of and 27,208 deaths resulting from lung cancer in a population of approximately 3 million were derived from the Cancer Surveillance of Shanghai between 2002 and 2017. Changes in stage-specific and histologic type-specific incidence and mortality and incidence rate ratio (IRR) relative to the base year 2002 or to the period 2002 through 2005 were calculated by sex and were used to evaluate potential overdiagnosisve of lung cancer. RESULTS: In men, both age-adjusted incidence of and mortality as a result of lung cancer decreased significantly up to 2008 and thereafter remained stable; in women, the incidence increased rapidly from 2011 (annual percentage change, 11.98%; 95% CI, 9.57%-14.45%), whereas the mortality declined persistently. The upward trend of incidence mainly was observed in lung adenocarcinoma in both sexes, with a sharper increase from 2012 through 2017. In men, the incidence of early-stage cancer increased 6.9 per 100,000 (95% CI, 5.1-8.7 per 100,000) and was accompanied by 5.5 per 100,000 (95% CI, -9.2 to -1.7 per 100,000) decline in late-stagecancer from 2002 through 2017. In women, early-stage incidence rose 16.1 per 100,000 (95% CI, 14.0-18.3 per 100,000), but no significant decline in late-stage cancer was found (absolute difference, -0.6 per 100,000; 95% CI, -2.8 to 1.7 per 100,000). The IRR was highest in most recent period and increased most in young women, mainly for early-stage cancer or lung adenocarcinoma. INTERPRETATION: The results provide evidence at a population level for lung cancer overdiagnosis in Chinese women resulting from increasing LDCT screening in the low-risk populations. Criteria for LDCT screening and management of screening-detected nodules need to be addressed fully for expanded application of LDCT screening in China.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Wang M, Lin S, He N, et al. The Introduction of Low-Dose CT Imaging and Lung Cancer Overdiagnosis in Chinese Women. Chest. 2022. PMID: 35998705. doi:10.1016/j.chest.2022.08.2207

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。